Cardiac Marker Analyzer Market Analysis By Key Companies ( Alere, Quidel Corporation, Roche, Beckman Coulter..), By Analyzers (PATHFAST Analyzer, The i-STAT System, RAMP Reader, RAMP 200..) - Global Market is Projected to Exceed USD 4.3 Billion By 2025

According to the new market research report “Cardiac Marker Analyzer Market Analysis By Key Companies ( Alere, Quidel Corporation, Roche, Beckman Coulter..), By Analyzers (PATHFAST Analyzer, The i-STAT System, RAMP Reader, RAMP 200..) - Global Market is Projected to Exceed USD 4.3 Billion By 2025.”

The Cardiac Marker Analyzer market research report displays the latest industry insights with future trends and analysis of the products and services, enabling you to deeply penetrate the market with high profitability. It also makes you aware of the leading competitors influencing the market along with the key factors to help you sustain your products or services with better forecast of demand and growth opportunities.

The global Cardiac Marker Analyzer market is projected to exceed USD 4.3 Billion by 2025. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Request Free Sample Research Report @ https://www.marketresearchnest.com/report/requestsample/426829

The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.

This 114 Page report with 9 Figures and 19 Tables has been studied from 7 View Points:

1. Cardiac Marker Analyzer Market and Forecast (2011 - 2025)
2. Cardiac Marker Companies - Comparative Tests Analysis
3. Cardiac Marker Analyzer - Competitive Product Analysis
4. Cardiac Marker Analyzer - Specifications, Product Features and Benefits Analysis
5. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
6. Emerging Markers Analysis
7. Companies Business and Marketing Strategy

Browse detail report with in-depth TOC @ https://www.marketresearchnest.com/Global-Cardiac-Marker-Analyzer-Market-Product-Analysis-Companies-Business-and-Marketing-Strategy-Major-Deals.html

Cardiac Marker Analyzer Covered in the report are as follows:

1. Triage MeterPro Analyzer
2. The i-STAT System
3. Cobas h 232 POC System
4. Access 2 Immunoassay System
5. Stratus CS Analyzer
6. RAMP 200
7. RAMP Reader
8. i-chroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. QL Care Analyzer
12. Meritas POC Analyzer

Cardiac Marker Analyzer - Key Companies Analysis

1. Alere (Now Abbott)
2. Abbott Point of Care
3. Quidel Corporation
4. Roche
5. Beckman Coulter
6. Siemens Healthineers
7. Response Biomedical
8. Boditech
9. Lifesign
10. LSI Medience Corporation
11. CardioGenics Holdings Inc.
12. Trinity Biotech.

If you have any special requirements, please let us know and we will offer you the report as you want.

The Cardiac Marker Analyzer research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs.
Key Highlights of the Report

• In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016.
• In 2017, Abbott Point of Care Diagnostics sales increased by 7.2 percent.
• Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.
• Quidel's cardiac immunoassay revenue was close to US$ 50 Million in 2017.
• A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.
• In February 2017, Siemens Healthineers announced a digital platform for healthcare providers as well as for providers of solutions and services.
• CardioGenics is the only company to successfully deploy CL in a compact, fully automated POC platform.
• Trinity Biotech Point-of-Care revenues for 2017 is likely to decline.
• In Jan. 2017, Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.
• Response Biomedical sells tests that detect three of the primary markers for the detection of an acute myocardial infarction: Troponin I, Myoglobin and CK-MB.

Inquire more about this report @ https://www.marketresearchnest.com/report/enquirybuy/426829

About Us:

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Contact Us

Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070
+44-20-3290-4151
Connect with us: Google+ | LinkedIn | Twitter | Facebook

This release was published on openPR.